²é¿´: 3617  |  »Ø¸´: 8
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

hoyelow

Ìú³æ (СÓÐÃûÆø)

[½»Á÷] Íâµ¼»ØÁ˼¸¸öÌ×´ÅÐÅ£¬ÈçºÎ»Ø¸´£¬¸÷λ֧¸öÕÐÒÑÓÐ6È˲ÎÓë

ÐĺÃÀÛ°¡£¬·¢ÁË30+Email£¬»ØÁ˼¸¸ö£¬´ó²¿·ÖûλÖÃÁË£¬¾Í»ØÁËÒÔϼ¸¸ö¡£Ê¦ÐÖʦ½ãÃÇÖ§¸öÕУ¬¶¼ÊÇʲôÒâ˼£¬ÎÒ¸ÃÔõô»Ø

µÚÒ»¸ö°Â¿ËÀ¼µÄ»ØÎÒ˵ûÓÐÇ®£¬ÈÃÎÒCSC
1.
Thank you for your email. I do have projects available on both gout and osteoarthritis and would be happy to talk to you about those to see if one of those may be a good fit for you. However there are some differences about the PhD programme in NZ compared to other countries which you may or may not be aware of and this may influence your decision to study here. In NZ, PhD students are required to obtain a scholarship or find some other means of supporting themselves through their study. This differs from many other countries where a student stipend is provided with a PhD project. There are University scholarships as well as other scholarships (eg Chinese Scholarship Council) available. I've included a link to the relevant page on our University website which describe the enrolment process (which is handled centrally) as well as the entry requirements and scholarship options.  Please let me know if you have any questions or would like to discuss the projects we have available.

µÚ¶þ¸ö»ØÎÒ˵ÈÃÎÒÖ®ºóÔÙÁªÏµËµÎÒµÄÓʼþºÜinteresting
2 . Many thanks for your interesting email.

It is difficult for me now to "reserve" a PhD position for next year - but I would encourage you to write me again, perhaps no later than next spring.

All the best with completing your studies!
µÚÈý¸ö˵ÈÃÎÒÖ±½ÓÍøÉê.ÎÒ¾õµÃÏ£Íû²»´ó£¬±Ï¾¹¿µÄζû
3.Thank you for your interest. You can apply through the GGD program and if you get in request to do a rotation with me.
µÚËĸöÀÏʦ˵ÓÃÎҵijɼ¨µ¥£¬·¢¹ýÈ¥¾Íû¶¯¾²ÁË£¬Ò»ÖÜÁËÒª²»ÒªÎÊÎÊ
4.I may be able to take you on. Can you send me a copy of your transcript since your grades really dictate admission and scholarship eligibility here.
µÚÎå¸öÀÏʦ»ØÎÒÒ»´ó¶Ñ£¬ÎÒ²»ÖªµÀÔõô»Ø¸¶ÁË
5.Thank you for sending me your CV and congratulation on your publication record. I think looking at your CV that you have gain some experience in molecular biology techniques and would be well placed to learn the techniques required for this project.

In this project you could either look at a few genes and using proteomic and genomic analysis prioritise this list for further study and validation in primary cells. Taking one gene forward for more detailed analysis in cells or in murine models of cardiovascular disease.

Alternatively you could take forward one of the more advanced genes and as well as having some focus on cell based assays use murine mouse models to look at the impact of loss or over expression of this gene on atherosclerosis.

It would depend if you would prefer a more cell based or animal model based project. Please let me know if you require any further information.

ÐĺÃÀÛ°¡£¬·½Ïò×îÒ»ÖµÄÀÏʦһֱû¶¯¾²
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

AFMMJACS

гæ (ÖøÃûдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÄãÕâ±¾ÉíÒ²¹»ÓÅÐãµÄ

·¢×ÔСľ³æAndroid¿Í»§¶Ë
4Â¥2019-11-03 15:43:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌøת ÎÒÒª¶©ÔÄÂ¥Ö÷ hoyelow µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍƼö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸¶«±±´óѧ²ÄÁÏר˶361·ÖÇóµ÷¼Á +3 ÐíÄãÍòÕɹââ 2024-03-28 4/200 2024-03-28 21:38 by EBSD
[¿¼ÑÐ] »¯Ñ§¹¤³ÌÓë¼¼Êõ×Ü·Ö320Çóµ÷¼Á +3 Wjrjxmt 2024-03-28 3/150 2024-03-28 20:32 by Ëæ·ç¶ø¶¯ß×
[¿¼ÑÐ] 287Çóµ÷¼Á +5 ÖØ»ñеÄÎÒ 2024-03-27 5/250 2024-03-28 20:12 by ÂóÌïÀïµÄÊØÍûÕß
[¿¼ÑÐ] ²ÄÁϵ÷¼Á281 Ò»Ö¾Ô¸ÎäÀíѧ˶ +4 »¨-- 2024-03-28 5/250 2024-03-28 20:05 by »¨--
[¿¼ÑÐ] 315Çóµ÷¼Á +4 ÎÞêdzÆ- 2024-03-28 4/200 2024-03-28 15:20 by vivian_sfw
[¿¼ÑÐ] 297Çóµ÷¼Á +4 ľľÂí¹þ¹þ 2024-03-27 4/200 2024-03-28 11:42 by -ÃÔÁË·°¡Â·
[¿¼ÑÐ] 301Çóµ÷¼Á +6 СӨ@ 2024-03-28 6/300 2024-03-28 11:21 by Áúɽ110
[¿¼ÑÐ] 301Çóµ÷¼Á +4 ÎÂ10086 2024-03-27 4/200 2024-03-28 11:17 by δÀ´¿ÉÆÚ¼òÖ±²»¶
[¿¼ÑÐ] Ò»Ö¾Ô¸´óÁ¬Àí¹¤´óѧ »¯Ñ§¹¤³Ìѧ˶ ×Ü·Ö351Çóµ÷¼Á +14 ÀîÉÌÒþÈëÊË 2024-03-23 16/800 2024-03-28 10:45 by Mango_2022
[¿¼ÑÐ] 307Çóµ÷¼Á +5 Ôç²ÍÍí²Í 2024-03-27 6/300 2024-03-27 23:02 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 290Çóµ÷¼Á +4 LÐèÒªµ÷¼Á 2024-03-27 4/200 2024-03-27 15:02 by δÀ´¿ÉÆÚ¼òÖ±²»¶
[¿¼ÑÐ] ÉúÎïѧ381Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÖÐɽ´óѧ +4 brix±´ 2024-03-26 6/300 2024-03-27 12:47 by brix±´
[ÂÛÎÄͶ¸å] ÓÐÈËͶ¹ýEnergyÆÚ¿¯Ã´£¿µ¼Ê¦ÊÇIEEE Fellow£¬»á²»»áÏñ±ðµÄIEEEÆÚ¿¯Ò»ÑùÓеãÕչˣ¿ 50+4 huanpo116 2024-03-26 4/200 2024-03-27 11:16 by ÏþÄ¿³ç
[¿¼ÑÐ] 304²ÄÁÏר˶Çóµ÷¼Á +9 ÑÌÔÆÄ«Óê·É°¡ 2024-03-23 11/550 2024-03-27 08:47 by y0203
[¿¼ÑÐ] 427Çóµ÷¼Á +3 echo586 2024-03-25 6/300 2024-03-26 14:54 by yumaomao2011
[¿¼ÑÐ] »¯Ñ§¹¤³ÌÓë¼¼Êõ320Çóµ÷¼Á +12 Wjrjxmt 2024-03-23 14/700 2024-03-26 13:01 by helloѽ6
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖйúÅ©Òµ´óѧ¹¤Ñ§ÔºÅ©Òµ¹¤³Ì350 Çóµ÷¼Á +3 24¿¼ÑÐ×Ð 2024-03-24 5/250 2024-03-26 00:28 by 24¿¼ÑÐ×Ð
[¿¼ÑÐ] 302Çóµ÷¼Á +7 С°×derÅí 2024-03-23 13/650 2024-03-24 15:06 by Ëæ·ç¶ø¶¯ß×
[¿¼ÑÐ] 329Çóµ÷¼Á +3 ÇÆÇÆÇǶù 2024-03-23 6/300 2024-03-23 12:25 by shangxh
[ÂÛÎÄͶ¸å] IEEE Transactions on Industrial InformaticsµÄÉó¸åÖÜÆÚÊǶà¾Ã£¿ +3 mollyzhang_2003 2024-03-22 5/250 2024-03-23 07:02 by mollyzhang_2003
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û